Company news

Apyx Medical Corporation news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2024 Financial Results on August 8, 2024

July 24, 2024

Apyx Medical Corporation Launches the "Renewing Lives" Give-Back Campaign Providing Treatments with Renuvion to Benefit Physical Appearance and Mental Health

June 25, 2024

Apyx Medical Corporation Reports First Quarter 2024 Financial Results; Reaffirms Full Year 2024 Financial Outlook

May 8, 2024

Apyx Medical Corporation Announces Board Leadership Transition

May 8, 2024

Apyx Medical Corporation to Release First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024

April 24, 2024

Apyx Medical Corporation Reports Fourth Quarter and Full Year 2023 Financial Results; Introduces Full Year 2024 Financial Outlook

March 20, 2024

Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2023 Financial Results on March 21, 2024

March 3, 2024

Apyx Medical Corporation Announces Peer-Reviewed Clinical Publication Evaluating the Safety of Renuvion® Following Liposuction in Multiple Areas of the Body

January 21, 2024

Apyx Medical Corporation Reports Preliminary Fourth Quarter and Full Year 2023 Revenue Results

January 7, 2024

Apyx Medical Corporation Appoints Matthew Hill as Chief Financial Officer

November 27, 2023

Apyx Medical Corporation Reports Third Quarter 2023 Financial Results and Updates Full Year 2023 Financial Outlook

November 8, 2023

Apyx Medical Corporation Announces New Debt Facility with Perceptive Advisors

November 8, 2023

Apyx Medical Corporation Reports Second Quarter 2023 Financial Results and Reaffirms Full Year 2023 Financial Outlook

August 9, 2023

Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2023 Financial Results on August 10, 2023

June 28, 2023

Apyx Medical Corporation Announces FDA 510(k) Clearance for the Renuvion® Micro Handpiece

June 13, 2023

Apyx Medical Corporation Reports First Quarter 2023 Financial Results and Updates Full Year 2023 Financial Outlook

May 10, 2023

Renuvion® receives FDA clearance for specific use after liposuction

May 1, 2023

Apyx Medical Corporation Receives FDA 510(k) Clearance for the Use of Renuvion® for Coagulation of Subcutaneous Soft Tissues Following Liposuction for Aesthetic Body Contouring

April 27, 2023

Apyx Medical Corporation Reports Fourth Quarter and Full Year 2022 Financial Results; Introduces Full Year 2023 Financial Outlook

March 15, 2023

Apyx Medical Corporation Receives FDA 510(k) Clearance for the Use of Renuvion® to Coagulate and Contract Soft Tissues, Including Subcutaneous Tissue, Where Needed

February 26, 2023

Apyx Medical Corporation Announces New Five-Year Credit Agreement with MidCap Financial

February 20, 2023

Apyx Medical Corporation Announces FDA 510(k) Submission for the Use of the Renuvion® APR Handpiece for the Coagulation of Subcutaneous Soft Tissues Where Needed, Following Liposuction

January 31, 2023

APYX Medical Corporation launches new 'APYX One Console' for cosmetic surgical procedures in the united states

January 24, 2023

Apyx Medical Corporation Reports Preliminary Fourth Quarter and Full Year 2022 Revenue Results

January 9, 2023

APYX® medical corporation embarks on inaugural brand campaign for Renuvion®

January 2, 2023

Apyx Medical Corporation Reports Third Quarter 2022 Financial Results and Updates Full Year 2022 Financial Outlook

November 9, 2022

Apyx Medical Corporation Reports Second Quarter 2022 Financial Results and Updates Full Year 2022 Financial Outlook

August 10, 2022

Apyx Medical Corporation Releases Environmental, Social and Governance Data in New Tear Sheet

July 26, 2022

Renuvion® cleared by FDA for neck laxity procedures offering patients a minimally invasive option to eliminate sagging neck

July 17, 2022

Apyx Medical Corporation Receives FDA 510(k) Clearance for the Use of Renuvion® to Improve Appearance of Lax (Loose) Skin

July 17, 2022

Apyx Medical Corporation Announces Results of the U.S. IDE Clinical Study Evaluating the Use of Renuvion to Improve the Appearance of Lax Skin in the Neck and Submental Region

July 7, 2022

Renuvion® dermal handpiece for wrinkle-reduction procedures cleared by FDA

June 27, 2022

Apyx Medical Corporation Receives FDA 510(k) Clearance for the Use of Renuvion® Cosmetic Technology in Dermal Resurfacing Procedures

May 25, 2022

Apyx Medical Corporation Reports First Quarter 2022 Financial Results and Updates Full Year 2022 Financial Outlook

May 11, 2022

Apyx Medical Corporation Announces FDA 510(k) Submission with Clinical Study Support for the Use of the Renuvion® APR Handpiece for Aesthetic Procedures to Improve Appearance of Lax Skin

April 3, 2022

Apyx Medical Corporation Reports Fourth Quarter and Full Year 2021 Financial Results; Introduces Full Year 2022 Financial Outlook

March 16, 2022

Apyx Medical Corporation Announces Peer-Reviewed Publication Featuring Results from the U.S. IDE Clinical Study Evaluating the Renuvion® Dermal Handpiece Using Apyx’s Helium Plasma Technology for Dermal Resurfacing Procedures

February 16, 2022

Apyx Medical Corporation Reports Preliminary Fourth Quarter and Full Year 2021 Revenue Results

January 9, 2022

Apyx Medical Corporation Reports Third Quarter 2021 Financial Results and Updates Full Year 2021 Outlook

November 10, 2021

Apyx Medical Corporation to Release Third Quarter of Fiscal Year 2021 Financial Results on November 11, 2021

October 3, 2021

Apyx Medical Corporation Announces Appointment of Wendy Levine to the Company’s Board of Directors

August 29, 2021

Apyx Medical Corporation Reports Second Quarter 2021 Financial Results and Updates Full Year 2021 Outlook

August 11, 2021

Apyx Medical Corporation Announces FDA 510(k) Submission for the Use of Renuvion® in Dermal Resurfacing Procedures

May 31, 2021

Apyx Medical Corporation Reports First Quarter 2021 Financial Results and Updates Full Year 2021 Outlook

May 11, 2021

Apyx Medical Corporation Reports Fourth Quarter and Full Year 2020 Financial Results; Introduces Full Year 2021 Financial Outlook

March 30, 2021

Apyx Medical Corporation Reports Preliminary Full Year and Fourth Quarter 2020 Revenue Results

January 12, 2021

Apyx Medical Corporation Announces Approval from FDA to Begin Phase II of U.S. IDE Study

November 22, 2020

Apyx Medical Corporation Reports Third Quarter 2020 Financial Results

November 8, 2020

Apyx Medical Corporation Announces Updates on U.S. IDE Clinical Studies

November 8, 2020

Apyx Medical Corporation Announces Two Peer-Reviewed Clinical Publications Evaluating Renuvion's Helium Plasma Technology

October 19, 2020

← Newer news releases · Older news releases →

Calls

The 5 newest of 22 calls. Every call is listed under its year.

Decks

The 5 newest of 12 decks. Every deck is listed under its year.